Skip to content

Federal Contractor Profile

The Univeristy Of Texas M.d. Anderson Cancer Center

$134M obligated·143 awards·4 agencies·21 NAICS

Federal Contracts

Showing award actions 101–150 of 178 funded award actions, most recent first.

Contracts with positive obligations
143
Funded award actions shown
178
Obligations shown
$134M
Awarding agencies
4

This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.

Award data as of September 10, 2026. Source: USAspending federal award records.

DateAgencyPIIDNAICSDescriptionAmount
Dec 18, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO75N98020F00003112990SQUIRREL MONKEY (SAIMIRI BOLIVIENSIS) EITHER GENDER, GREATER THAN 700 GRAMS, SPF IAW REQUIREMENTS NOTED IN RFQ N47 (263201600013I)$37K
Nov 15, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO75N98020F00001112990OWL MONKEYS (AOTUS NANCYMAAE) GENDER MIXED, IAW RFQ N45 (263201600013I)$153K
Sep 27, 2019Department of Health and Human ServicesHRSA HEADQUARTERS75R60219C00004621991NATIONAL CORD BLOOD INVENTORY$8.5M
Sep 16, 2019Department of Health and Human ServicesNIH NCIHHSN26100011541712IGF::OT::IGF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF 4-HYDROXYTAMOXIFEN TOPICAL GEL IN WOMEN WITH MAMMOGRAPHICALLY DENSE BREASTS$692K
Sep 13, 2019Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40119C10129541714STUDY - MODULAR APPLICATION OF SURFACE TECHNOLOGY FOR THE GENERATION OF ANTIGEN-SPECIFIC T CELLS - BAAPMQWP#217$561K
Sep 10, 2019Department of Health and Human ServicesNIH NCI75N91019F00129541712OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH$724K
Sep 10, 2019Department of Health and Human ServicesNIH NCIHHSN26100009541712IGF::OT::IGF VADIS TRIAL: PHASE II TRIAL OF E75 PEPTIDE VACCINE IN WOMEN WITH DCIS OF THE BREAST$58K
Sep 10, 2019Department of Health and Human ServicesNIH NCI75N91019F00131541714REPURPOSING OF MACROLIDE ANTIBIOTIC CLARITHROMYCIN FOR THE PREVENTION OF LUNG AND BREAST CANCER$919K
Sep 9, 2019Department of Health and Human ServicesNIH NCI75N91019F00132541714CANCER PREVENTION BY VACCINATION AGAINST INDUCED ANTIGENS$1.2M
Sep 7, 2019Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VAN0018319P082161131006MV PHOTON$2K
Aug 29, 2019Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VAN0018319P0806611310QUALITY AUDIT PROGRAM$600
Aug 12, 2019Department of Health and Human ServicesNIH NCIHHSN26100004541711IGF::OT::IGF DETERMINATION OF DOSING REGIMENS OF ERLOTINIB IN COMBINATION WITH SULINDAC FOR PREVENTION OF COLORECTAL CANCER WHILE REDUCING AGENT TOXICITY POP 06/01/2017 - 05/31/2019$204K
Jul 15, 2019Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES75D30119C05279611210INVASIVE MOLD DATA ACQUISITION$151K
Jun 24, 2019Department of Health and Human ServicesNIH NCI75N91019F00130541714OPTIMIZATION OF DOSING REGIMENTS OF SULINDAC IN COMBINATION WITH ERLOTINIB FOR SMALL INTESTINAL AND COLON CANCER PREVENTION$854K
Jun 20, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO75N98019F00847112990BEAGLES, MALE, 18 - 30 MONTH OF AGE; 9 - 14 KGS, IAW CONTRACT SOW (263201400013I)$33K
May 15, 2019Department of Health and Human ServicesNIH NCIHHSN26100008541712IGF::OT::IGF ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RANDOMIZED PRESURGICAL TRIAL$30K
May 14, 2019Department of Health and Human ServicesNIH NCIHHSN26100011541712IGF::OT::IGF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF 4-HYDROXYTAMOXIFEN TOPICAL GEL IN WOMEN WITH MAMMOGRAPHICALLY DENSE BREASTS$790K
Apr 19, 2019Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40119P10151112990BORDETELLA-FREE WEANLING BABOONS$188K
Apr 1, 2019Department of DefenseFA8601 AFLCMC PZIOFA860119P0316622310RATIFICATION FOR MD ANDERSON$8K
Mar 27, 2019Department of Health and Human ServicesNIH NCIHHSN26100012541712IGF::OT::IGF A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER$102K
Oct 19, 2018Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VAN0018318P0888611310IGF::OT::IGF AUDIT PROGRAM$400
Sep 25, 2018Department of Health and Human ServicesHRSA HEADQUARTERSHHSH250201000011C621991TAS::75 0350::TAS - PROVIDE FOR THE COLLECTION AND MAINTENANCE OF GENETICALLY DIVERSE, HIGH-QUALITY UMBILICAL CORD BLOOD UNITS FOR INCLUSION IN THE NATIONAL CORD BLLOD INVENTORY$7.7M
Sep 21, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO75N98018F00010112990OWL MONKEYS (AOTUS NANCYMAAE) ADULTS, MIXED GENDER, IAW RFQ N12 (263201600013I)$82K
Sep 20, 2018Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VAN0018318P0882611310IGF::OT::IGF AUDIT PROGRAM$600
Sep 20, 2018Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VAN0018318P0888611310IGF::OT::IGF AUDIT PROGRAM$2K
Sep 17, 2018Department of Health and Human ServicesNIH NCI75N91018F00008541711TARGETING THE RXR PATHWAY FOR THE PREVENTION OF TRIPLE-NEGATIVE BREAST CANCER HHSN2612015000181 TASK ORDER 9$778K
Sep 17, 2018Department of Health and Human ServicesNIH NCI75N91018F00009541711RANK LIGAND INHIBITION - A POTENTIAL CHEMOPREVENTION STRATEGY FOR WOMEN AT HIGH GENETIC RISK OF BREAST CANCER HHSN2612015000181 TO: HHSN26100008 PP: 9/17/18 TO 3/16/2021$643K
Aug 30, 2018Department of Health and Human ServicesNIH NCIHHSN26100010541712IGF::OT::IGF CORE INFRASTRUCTURE SUPPORT$94K
Aug 14, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO75N98018F00009112990PER DIEM AND TESTING TO SUPPORT THE NIAID OWNED AOTUS GRISEIMEMBRA COLONY- MD ANDERSON$110K
Jul 20, 2018Department of Health and Human ServicesNIH NCI75N91018F00007541711PREVENTION OF HEPATOCELLULAR CARCINOMA (HCC) ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH)$733K
Jul 6, 2018Department of Health and Human ServicesNIH NCIHHSN26100010541712IGF::OT::IGF CORE INFRASTRUCTURE SUPPORT$1.1M
May 25, 2018Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VAN0018317P0961611310IGF::OT::IGF AUDIT PROGRAM$500
Apr 23, 2018Department of Health and Human ServicesNIH NCIHHSN26100008541712IGF::OT::IGF ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RANDOMIZED PRESURGICAL TRIAL$865K
Apr 10, 2018Department of Veterans AffairsRPO EAST (36C24E)36C24E18C0032541715RPPA ANALYSIS$23K
Mar 12, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAOHHSN26300008112990SQUIRREL MONKEY, BOLIVIAN, SPF, EVEN GENDER SPLIT IN ACCORDANCE WITH RFQ NDA2 (HHSN263201600013I) CAN 8338095$60K
Jan 11, 2018Department of Health and Human ServicesNIH NCIHHSN26100006541711IGF::OT::IGF TARGETING THE MTOR PATHWAY FOR THE PREVENTION OF BREAST CANCER$38K
Dec 8, 2017Department of Veterans Affairs242-NETWORK CONTRACT OFFICE 02 (36C242)36C24218P0469811219IGF::OT::IGF NJ RADIATION CALIBRATIONS$6K
Oct 1, 2017Department of Veterans AffairsRPO EAST (36C24E)VA24018J0407541712RESEARCH AFFILIATE SERVICES$62K
Sep 27, 2017Department of Veterans AffairsDEPT OF VETERANS AFFAIRS (00741)VA74115C0021541690IGF::OT::IGF PEER REVIEW OF RADIATION QA OPERATIONS$354K
Sep 19, 2017Department of Health and Human ServicesNIH NCIHHSN26100013541712IGF::OT::IGF PILOT STUDY OF DENOSUMAB IN BRCA1/2 MUTATION CARRIERS SCHEDULED FOR RISK-REDUCING SALPINGO-OOPHERECTOMY$524K
Sep 15, 2017Department of Health and Human ServicesNIH NCIHHSN26100006541711IGF::OT::IGF TARGETING THE MTOR PATHWAY FOR THE PREVENTION OF BREAST CANCER$681K
Sep 13, 2017Department of Veterans AffairsRPO EAST (36C24E)VA24017C0100541712IGF::OT::IGF GENOME SEQUENCING$440K
Sep 12, 2017Department of Health and Human ServicesNIH NCIHHSN26100010541712IGF::OT::IGF CORE INFRASTRUCTURE SUPPORT$1.1M
Sep 7, 2017Department of Health and Human ServicesNIH NCIHHSN26100012541712IGF::OT::IGF A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER$382K
Sep 1, 2017Department of Health and Human ServicesHRSA HEADQUARTERSHHSH250201000011C621991TAS::75 0350::TAS - PROVIDE FOR THE COLLECTION AND MAINTENANCE OF GENETICALLY DIVERSE, HIGH-QUALITY UMBILICAL CORD BLOOD UNITS FOR INCLUSION IN THE NATIONAL CORD BLLOD INVENTORY$5.3M
Aug 15, 2017Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VAN0018317P0961611310IGF::OT::IGF AUDIT PROGRAM$600
Aug 7, 2017Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VAN0018317P0930611310IGF::OT::IGF AUDIT PROGRAM$600
Jul 18, 2017Department of Health and Human ServicesNIH NCIHHSN26100009541712IGF::OT::IGF VADIS TRIAL: PHASE II TRIAL OF E75 PEPTIDE VACCINE IN WOMEN WITH DCIS OF THE BREAST$13K
Jun 20, 2017Department of Health and Human ServicesNIH NCIHHSN26100005541711IGF::OT::IGF TARGETED CASEIN KINASE INHIBITION AS A BREAST CANCER PREVENTION$508K
Jun 6, 2017Department of Veterans Affairs242-NETWORK CONTRACT OFFICE 02 (36C242)VA24217P2659811219UNAUTHORIZED COMMITMENT NJ LTD SERVICES IGF::OT::IGF$17K

Get Alerted Before The Univeristy Of Texas M.d. Anderson Cancer Center's Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start for free